Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Multiple Myeloma 24Lymphoma 16Neoplasms, Plasma Cell 12Lymphoma, Non-Hodgkin 11Lymphoma, Large B-Cell, Diffuse 8Neuroblastoma 7Lymphoma, Mantle-Cell 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Hodgkin Disease 6Myelodysplastic Syndromes 5Lymphoma, Large-Cell, Immunoblastic 5Leukemia 5Burkitt Lymphoma 5Lymphoma, Follicular 4Leukemia, Lymphocytic, Chronic, B-Cell 4Recurrence 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Myeloid, Chronic-Phase 3Leukemia, Myeloid, Acute 3Sarcoma 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Neuroectodermal Tumors, Primitive, Peripheral 2Neuroectodermal Tumors, Primitive 2Medulloblastoma 2Lymphoma, T-Cell 2Lymphoma, Large-Cell, Anaplastic 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Biphenotypic, Acute 2Dendritic Cell Sarcoma, Interdigitating 2Brain Neoplasms 2

Interventions

Hyperthermic Intraperitoneal Chemotherapy 8Neoadjuvant Therapy 3Paclitaxel 2Mitomycin 2Cytoreduction Surgical Procedures 2Cisplatin 2lobaplatin 1Therapeutics 1Taxes 1Surgical Procedures, Operative 1Oxaliplatin 1Nivolumab 1Melphalan 1Laparoscopy 1LAIF 900 1Hypericum extract LI 160 1Food, Formulated 1Drug Therapy 1Chemotherapy, Adjuvant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Peritoneal Neoplasms × Melphalan × Clear all
NCT03073694 2023-06-09

Comparing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) Using Mitomycin-C Versus Melphalan for Colorectal Peritoneal Carcinomatosis

University of Kansas Medical Center

Phase 2 Unknown
100 enrolled
GastrointestinalGynecologic

Appendiceal Neoplasms, Peritoneal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡